Staff Scientist

The Nelson research group at Fred Hutchinson Cancer Center is seeking a highly motivated Staff Scientist to lead multiple projects focused on androgen receptor (AR) biochemistry and pathobiology in prostate cancer.

About the Organization

Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington. With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy, and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease, and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy, and related services, with network affiliations across five states. The organization values collaboration, compassion, determination, excellence, innovation, integrity, and respect, and is committed to learning across differences to strengthen its mission.

Responsibilities

• Design and conduct experiments to determine mechanisms of AR activity in prostate cancer.
• Design and conduct experiments identifying pathways and drugs that exploit AR signaling pathways in cancer and benign cells.
• Design and conduct genetic and small molecule screens for vulnerabilities in models of advanced prostate cancer.
• Perform bioinformatics and statistical analyses of public and private datasets of gene expression and genomics in advanced prostate cancer.
• Develop independent research projects suitable for external funding proposals.
• Document experimental research in formats appropriate for presentations, publications, and grant proposals.
• Assist the Principal Investigator with projects, including supervising, training, and mentoring laboratory members.

Qualifications

Minimum Qualifications:

• Doctoral degree or equivalent in biology, biochemistry, molecular biology, pharmacology, immunology, or genetics.
• Post-doctoral or research experience in a field relating to oncology: endocrinology, genomics, genetics, metastasis, drug and gene delivery systems, immunology, or immunotherapy.
• Evidence of independent research, including publications in peer-reviewed journals and successful grant funding.
• Experience in supervisory and project management in an academic or biotechnology setting.
• Capacity to develop new research techniques and adapt to a fast-paced environment.
• Excellent verbal and written communication skills.

Preferred Qualifications:

• Experience performing standard cell, histology, and molecular biology techniques, including RNAseq and ChIPseq.
• Experience working with in vivo systems, including genetically modified and syngeneic mouse tumor models.
• Experience with rapid screening of new technologies intended to enhance drug and biologics delivery.
• Experience in the development and characterization of genetically engineered mouse models.
• Ability to work in a cross-functional environment with engineers, biologists, and medical doctors.
• Development of protocols (e.g., IACUC and IRB), work plans for externally funded research agreements, and experience writing and submitting research grants to funding agencies.

Pay

The annual base salary range for this position is from $84,406 to $191,755, with pay offered based on experience and qualifications.

Benefits

• Medical, vision, and dental coverage.
• Flexible spending accounts.
• Life and disability insurance.
• Retirement plans.
• Family life support and employee assistance program.
• Onsite health clinic.
• Tuition reimbursement.
• Paid vacation (22 days per year).
• Paid sick leave (up to 30 calendar days per occurrence of a qualifying reason).
• Paid holidays (up to 13 days per year).
• Paid parental leave (up to 4 weeks).

Candidates who already hold an H-1B visa sponsored by another organization and are currently in the U.S. may be eligible for this position.